Shield is first blood test approved by FDA as a primary screening option for colorectal cancer and that meets performance requirements for Medicare coverage Blood test offers easy, convenient and ...

PALO ALTO, Calif., March 25, 2025--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer (CRC) screening is now ...

The Shield blood test is FDA approved for primary non-invasive screening for colorectal cancer in average-risk individuals age 45 and older. For more information, visit www.ShieldCancerScreen.com.

Guardant Health (GH) announced that the National Comprehensive Cancer Network, NCCN, has included the Shield blood test in its updated colorectal cancer, CRC, screening guidelines.

The U.S. Food and Drug Administration on Monday approved Shield from Guardant Health, a new blood test that can spot colon cancer.

July 29, 2024 First blood test for colorectal cancer offers a less invasive screening option than colonoscopies Guardant Health's Shield test, approved by the FDA, requires less prep work and ...

Guardant Health’s FDA-approved Shield™ Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer Aug. 01, 2024 8:30 AM ET Guardant Health, Inc. (GH) ...

Guardant Health, Inc., a leading precision oncology company, today announced the Centers for Medicare& Medicaid Services has approved Advanced Diagnostic Laboratory Test status for the Shield ...

PALO ALTO, Calif., July 29, 2024--The FDA has approved the Shield test from Guardant Health, the first blood test approved as a primary screening option for colorectal cancer.

Guardant Health, Inc., a leading precision oncology company, today announced the U.S. Food and Drug Administration has approved the company’ s Shield™ blood test for colorectal cancer ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Shield™ blood test for ...